Airway host-microbiome interactions in chronic obstructive pulmonary disease

Area of Science:

• Microbiome research
• Pulmonary medicine
• Immunology

Background:

• Limited understanding of lung microbiome and host response in COPD.
• Chronic obstructive pulmonary disease (COPD) is a major global health concern.

Purpose of the Study:

• To investigate the interplay between the lung microbiome and host immune response in COPD.
• To identify specific microbial and host factors associated with COPD inflammation and exacerbations.

Main Methods:

• Longitudinal 16S rRNA gene-based microbiome survey of sputum samples from healthy subjects and COPD patients.
• Characterization of host sputum transcriptome and proteome in COPD patients.
• Multivariate modeling to associate microbiome profiles with host factors.

Main Results:

• Sputum microbiome dysbiosis observed in COPD, with increased Moraxella and Haemophilus.
• Moraxella and Haemophilus associated with host interferon, pro-inflammatory pathways, and neutrophilic inflammation.
• Haemophilus linked to host factors in stable COPD and exacerbations; Moraxella linked to exacerbations.

Conclusions:

• Significant airway host-microbiome interplay identified in COPD.
• Haemophilus and Moraxella influence distinct host immune responses in COPD.
• Therapeutic strategies targeting these bacteria and associated pathways are suggested for COPD treatment.